Signal transducers and activators of transcription 5 contributes to erythropoietin-mediated neuroprotection against hippocampal neuronal death after transient global cerebral ischemia

Neurobiology of Disease

Volumn 25, Issue 1, 2007, Pages 45-53

  Zhang, Feng ^a   Wang, Suping ^a   Cao, Guodong ^a,b   Gao, Yanqin ^b   Chen, Jun ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b FUDAN UNIVERSITY   (China)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

CA1; EPO; Ischemia; STAT5

Indexed keywords

JANUS KINASE 2; PROTEIN BCL XL; RECOMBINANT ERYTHROPOIETIN; STAT5 PROTEIN; TYRPHOSTIN; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN NERVE CELL; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; CELL DEATH; ERYTHROPOIETIN; HIPPOCAMPUS; IMMUNOPRECIPITATION; IN SITU NICK-END LABELING; ISCHEMIC ATTACK, TRANSIENT; JANUS KINASE 2; MALE; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 33751114189     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.08.007     Document Type: Article

References (47)

1. Aaronson D.S., and Horvath C.M. A road map for those who don't know JAK-STAT. Science 296 (2002) 1653-1655
2. Battle T.E., and Frank D.A. The role of STATs in apoptosis. Curr. Mol. Med. 2 (2002) 381-392
3. Boer A.K., Drayer A.L., Rui H., and Vellenga E. Prostaglandin-E2 enhances EPO-mediated STAT5 transcriptional activity by serine phosphorylation of CREB. Blood 100 (2002) 467-473
4. Boer A.K., Drayer A.L., and Vellenga E. Stem cell factor enhances erythropoietin-mediated transactivation of signal transducer and activator of transcription 5 (STAT5) via the PKA/CREB pathway. Exp. Hematol. 31 (2003) 512-520
5. Calapai G., Marciano M.C., Corica F., Allegra A., Parisi A., Frisina N., Caputi A.P., and Buemi M. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur. J. Pharmacol. 401 (2000) 349-356
6. Cao G., Luo Y., Nagayama T., Pei W., Stetler R.A., Graham S.H., and Chen J. Cloning and characterization of rat caspase-9: implications for a role in mediating caspase-3 activation and hippocampal cell death after transient cerebral ischemia. J. Cereb. Blood Flow Metab. 22 (2002) 534-546
7. Cao G., Clark R.S., Pei W., Yin W., Zhang F., Sun F.Y., Graham S.H., and Chen J. Translocation of apoptosis-inducing factor in vulnerable neurons after transient cerebral ischemia and in neuronal cultures after oxygen-glucose deprivation. J. Cereb. Blood Flow Metab. 23 (2003) 1137-1150
8. Catania M.A., Marciano M.C., Parisi A., Sturiale A., Buemi M., Grasso G., Squadrito F., Caputi A.P., and Calapai G. Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils. Eur. J. Pharmacol. 437 (2002) 147-150
9. Chen J., Nagayama T., Jin K., Stetler R.A., Zhu R.L., Graham S.H., and Simon R.P. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosci. 18 (1998) 4914-4928
10. Chong Z.Z., Kang J.Q., and Maiese K. Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J. Cereb. Blood Flow Metab. 22 (2002) 503-514
11. Damen J.E., Wakao H., Miyajima A., Krosl J., Humphries R.K., Cutler R.L., and Krystal G. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J. 14 (1995) 5557-5568
12. Debierre-Grockiego F. Anti-apoptotic role of STAT5 in haematopoietic cells and in the pathogenesis of malignancies. Apoptosis 9 (2004) 717-728
13. De-Fraja C., Conti L., Magrassi L., Govoni S., and Cattaneo E. Members of the JAK/STAT proteins are expressed and regulated during development in the mammalian forebrain. J. Neurosci. Res. 54 (1998) 320-330
14. De-Fraja C., Conti L., Govoni S., Battaini F., and Cattaneo E. STAT signalling in the mature and aging brain. Int. J. Dev. Neurosci. 18 (2000) 439-446
15. Digicaylioglu M., and Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412 (2001) 641-647
16. Dudley A.C., Thomas D., Best J., and Jenkins A. A VEGF/JAK2/STAT5 axis may partially mediate endothelial cell tolerance to hypoxia. Biochem. J. 390 (2005) 427-436
17. Ehret G.B., Reichenbach P., Schindler U., Horvath C.M., Fritz S., Nabholz M., and Bucher P. DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J. Biol. Chem. 276 (2001) 6675-6688
18. Elmer E., Kokaia Z., Kokaia M., Carnahan J., Nawa H., and Lindvall O. Dynamic changes of brain-derived neurotrophic factor protein levels in the rat forebrain after single and recurring kindling-induced seizures. Neuroscience 83 (1998) 351-362
19. Fan Y.-F., Lu C.-Z., Xie J., Zhao Y.-X., and Yang G.-Y. Apoptosis inhibition in ischemic brain by intraperitoneal PTD-BIR3-RING (XIAP). Neurochem. Int. 48 (2006) 50-59
20. Finkbeiner S., Tavazoie S.F., Maloratsky A., Jacobs K.M., Harris K.M., and Greenberg M.E. CREB: a major mediator of neuronal neurotrophin responses. Neuron 19 (1997) 1031-1047
21. Gesbert F., and Griffin J.D. Bcr/Abl activates transcription of the Bcl-X gene through STAT5. Blood 96 (2000) 2269-2276
22. Gewinner C., Hart G., Zachara N., Cole R., Beisenherz-Huss C., and Groner B. The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5. J. Biol. Chem. 279 (2004) 3563-3572
23. Gobert S., Chretien S., Gouilleux F., Muller O., Pallard C., Dusanter-Fourt I., Groner B., Lacombe C., Gisselbrecht S., and Mayeux P. Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. EMBO J. 15 (1996) 2434-2441
24. Kirito K., Watanabe T., Sawada K., Endo H., Ozawa K., and Komatsu N. Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways. J. Biol. Chem. 277 (2002) 8329-8337
25. Liu X., Robinson G.W., Gouilleux F., Groner B., and Hennighausen L. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 8831-8835
26. Mohapatra S., Chu B., Wei S., Djeu J., Epling-Burnette P.K., Loughran T., Jove R., and Pledger W.J. Roscovitine inhibits STAT5 activity and induces apoptosis in the human leukemia virus type 1-transformed cell line MT-2. Cancer Res. 63 (2003) 8523-8530
27. Nagayama T., Lan J., Henshall D.C., Chen D., O'Horo C., Simon R.P., and Chen J. Induction of oxidative DNA damage in the peri-infarct region after permanent focal cerebral ischemia. J. Neurochem. 75 (2000) 1716-1728
28. Nyga R., Pecquet C., Harir N., Gu H., Dhennin-Duthille I., Regnier A., Gouilleux-Gruart V., Lassoued K., and Gouilleux F. Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter. Biochem. J. 390 (2005) 359-366
29. Parganas E., Wang D., Stravopodis D., Topham D.J., Marine J.-C., Teglund S., Vanin E.F., Bodner S., Colamonici O.R., and van Deursen J.M. Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93 (1998) 385-395
30. Park S.H., Liu X., Hennighausen L., Davey H.W., and Waxman D.J. Distinctive roles of STAT5a and STAT5b in sexual dimorphism of hepatic P450 gene expression. Impact of STAT5a gene disruption. J. Biol. Chem. 274 (1999) 7421-7430
31. Paukku K., and Silvennoinen O. STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5. Cytokine Growth Factor Rev. 15 (2004) 435-455
32. Rosa Santos S.C., Dumon S., Mayeux P., Gisselbrecht S., and Gouilleux F. Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line. Oncogene 19 (2000) 1164-1172
33. Ruscher K., Freyer D., Karsch M., Isaev N., Megow D., Sawitzki B., Priller J., Dirnagl U., and Meisel A. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci. 22 (2002) 10291-10301
34. Sakanaka M., Wen T.C., Matsuda S., Masuda S., Morishita E., Nagao M., and Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 4635-4640
35. Siegelin M.D., Kossatz L.S., Winckler J., and Rami A. Regulation of XIAP and Smac/DIABLO in the rat hippocampus following transient forebrain ischemia. Neurochem. Int. 46 (2005) 41-51
36. Siren A.L., Fratelli M., Brines M., Goemans C., Casagrande S., Lewczuk P., Keenan S., Gleiter C., Pasquali C., Capobianco A., Mennini T., Heumann R., Cerami A., Ehrenreich H., and Ghezzi P. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 4044-4049
37. Socolovsky M., Fallon A.E., Wang S., Brugnara C., and Lodish H.F. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/-mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 98 (1999) 181-191
38. Sola A., Rogido M., Lee B.H., Genetta T., and Wen T.C. Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats. Pediatr. Res. 57 (2005) 481-487
39. Takahashi R., Deveraux Q., Tamm I., Welsh K., Assa-Munt N., Salvesen G.S., and Reed J.C. A single BIR domain of XIAP sufficient for inhibiting caspases. J. Biol. Chem. 273 (1998) 7787-7790
40. Teglund S., McKay C., Schuetz E., van Deursen J.M., Stravopodis D., Wang D., Brown M., Bodner S., Grosveld G., and Ihle J.N. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93 (1998) 841-850
41. Um M., and Lodish H.F. Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathways. J. Biol. Chem. 281 (2006) 5648-5656
42. Viviani B., Bartesaghi S., Corsini E., Villa P., Ghezzi P., Garau A., Galli C.L., and Marinovich M. Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor. J. Neurochem. 93 (2005) 412-421
43. Wen T.C., Sadamoto Y., Tanaka J., Zhu P.X., Nakata K., Ma Y.J., Hata R., and Sakanaka M. Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expression. J. Neurosci. Res. 67 (2002) 795-803
44. Yamaura G., Turoczi T., Yamamoto F., Siddqui M.A., Maulik N., and Das D.K. STAT signaling in ischemic heart: a role of STAT5A in ischemic preconditioning. Am. J. Physiol., Heart Circ. Physiol. 285 (2003) H476-H482
45. Zhang S., Fukuda S., Lee Y., Hangoc G., Cooper S., Spolski R., Leonard W.J., and Broxmeyer H.E. Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling. J. Exp. Med. 192 (2000) 719-728
46. Zhang F., Yin W., and Chen J. Apoptosis in cerebral ischemia: executional and regulatory signaling mechanisms. Neurol. Res. 26 (2004) 835-845
47. Zhang F., Signore A.P., Zhou Z., Wang S., Cao G., and Chen J. Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signaling mechanisms. J. Neurosci. Res. 83 (2006) 1241-1251